Search Results

There are 16774 results for: content related to: Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease

  1. Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease

    Movement Disorders

    Volume 25, Issue 14, 30 October 2010, Pages: 2326–2332, Olivier Rascol, Paolo Barone, Robert A. Hauser, Yoshikuni Mizuno, Werner Poewe, Anthony H.V. Schapira, Laurence Salin, Mandy Sohr, Catherine Debieuvre and for the Pramipexole Switch Study Group

    Article first published online : 28 JUL 2010, DOI: 10.1002/mds.23262

  2. You have free access to this content
    Comparison of pramipexole with and without domperidone co-administration on alertness, autonomic, and endocrine functions in healthy volunteers

    British Journal of Clinical Pharmacology

    Volume 64, Issue 5, November 2007, Pages: 591–602, Ebony R. Samuels, Ruihua H. Hou, Robert W. Langley, Elemer Szabadi and Christopher M. Bradshaw

    Article first published online : 19 JUN 2007, DOI: 10.1111/j.1365-2125.2007.02938.x

  3. Pramipexole for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke, Julie Speller and J A Clarke

    Published Online : 24 APR 2000, DOI: 10.1002/14651858.CD002261

  4. You have full text access to this OnlineOpen article
    Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease

    European Journal of Neurology

    Volume 21, Issue 5, May 2014, Pages: 736–743, R. A. Hauser, A. H. V. Schapira, P. Barone, Y. Mizuno, O. Rascol, M. Busse, C. Debieuvre, M. Fraessdorf, W. Poewe and for the Pramipexole ER Studies Group

    Article first published online : 4 FEB 2014, DOI: 10.1111/ene.12375

  5. Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2542–2549, Robert A. Hauser, Anthony H.V. Schapira, Olivier Rascol, Paolo Barone, Yoshikuni Mizuno, Laurence Salin, Monika Haaksma, Nolwenn Juhel and Werner Poewe

    Article first published online : 10 NOV 2010, DOI: 10.1002/mds.23317

  6. Dopamine agonists for the treatment of restless legs syndrome

    Intervention Review

    The Cochrane Library

    Hanna Scholz, Claudia Trenkwalder, Ralf Kohnen, Levente Kriston, Dieter Riemann and Magdolna Hornyak

    Published Online : 15 MAR 2011, DOI: 10.1002/14651858.CD006009.pub2

  7. Long-term treatment with pramipexole in restless legs syndrome

    European Journal of Neurology

    Volume 13, Issue 12, December 2006, Pages: 1306–1311, J. Montplaisir, M. L. Fantini, A. Desautels, M. Michaud, D. Petit and D. Filipini

    Article first published online : 13 NOV 2006, DOI: 10.1111/j.1468-1331.2006.01459.x

  8. Pre-clinical studies of pramipexole: clinical relevance

    European Journal of Neurology

    Volume 7, Issue s1, May 2000, Pages: 15–20, J. P. Hubble

    Article first published online : 4 JAN 2002, DOI: 10.1046/j.1468-1331.2000.0070s1015.x

  9. Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Carl E Clarke, Julie Speller and J A Clarke

    Published Online : 24 APR 2000, DOI: 10.1002/14651858.CD002259

  10. You have free access to this content
    Pramipexole protects against MPTP toxicity in non-human primates

    Journal of Neurochemistry

    Volume 96, Issue 5, March 2006, Pages: 1315–1321, Mahmoud M. Iravani, Claire O. Haddon, J. Mark Cooper, Peter Jenner and Anthony H. Schapira

    Article first published online : 8 FEB 2006, DOI: 10.1111/j.1471-4159.2005.03625.x

  11. Efficacy of pramipexole in restless legs syndrome: A six-week, multicenter, randomized, double-blind study (effect-RLS study)

    Movement Disorders

    Volume 22, Issue 2, 15 January 2007, Pages: 213–219, Wolfgang H. Oertel, Karin Stiasny-Kolster, Bettina Bergtholdt, Yngve Hallström, Jaan Albo, Lena Leissner, Thomas Schindler, Juergen Koester and Juergen Reess

    Article first published online : 28 NOV 2006, DOI: 10.1002/mds.21261

  12. Pramipexole modulates the neural network of reward anticipation

    Human Brain Mapping

    Volume 32, Issue 5, May 2011, Pages: 800–811, Zheng Ye, Anke Hammer, Estela Camara and Thomas F. Münte

    Article first published online : 9 JUN 2010, DOI: 10.1002/hbm.21067

  13. Pramipexole combined with levodopa improves motor function but reduces dyskinesia in MPTP-treated common marmosets

    Movement Disorders

    Volume 25, Issue 3, 15 February 2010, Pages: 377–384, Kayhan A. Tayarani-Binazir, Michael J. Jackson, Sarah Rose, C. Warren Olanow and Peter Jenner

    Article first published online : 27 JAN 2010, DOI: 10.1002/mds.22960

  14. You have free access to this content
    Pramipexole protects against apoptotic cell death by non-dopaminergic mechanisms

    Journal of Neurochemistry

    Volume 91, Issue 5, December 2004, Pages: 1075–1081, Mei Gu, M. Irvani, J Mark Cooper, Diane King, Peter Jenner and Anthony H. V. Schapira

    Article first published online : 28 OCT 2004, DOI: 10.1111/j.1471-4159.2004.02804.x

  15. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Article first published online : 6 JUN 2014, DOI: 10.1002/mds.25914

  16. Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: Results from a European multicenter trial

    Movement Disorders

    Volume 20, Issue 5, May 2005, Pages: 602–610, J. Carsten Möller, Wolfgang H. Oertel, Jürgen Köster, Gianni Pezzoli and Leandro Provinciali

    Article first published online : 22 FEB 2005, DOI: 10.1002/mds.20397

  17. You have free access to this content
    Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

    European Journal of Neurology

    Volume 20, Issue 1, January 2013, Pages: 5–15, J. J. Ferreira, R. Katzenschlager, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, A. Schapira, A. Berardelli and W. H. Oertel

    Article first published online : 22 DEC 2012, DOI: 10.1111/j.1468-1331.2012.03866.x

  18. You have free access to this content
    A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

    Arthritis & Rheumatism

    Volume 52, Issue 8, August 2005, Pages: 2495–2505, Andrew J. Holman and Robin R. Myers

    Article first published online : 28 JUL 2005, DOI: 10.1002/art.21191

  19. An open-label conversion study of pramipexole to ropinirole prolonged release in Parkinson's disease

    Movement Disorders

    Volume 24, Issue 14, 30 October 2009, Pages: 2121–2127, Kelly E. Lyons and Rajesh Pahwa

    Article first published online : 18 SEP 2009, DOI: 10.1002/mds.22750

  20. Pregnancy outcome following use of levodopa, pramipexole, ropinirole, and rotigotine for restless legs syndrome during pregnancy: a case series

    European Journal of Neurology

    Volume 20, Issue 9, September 2013, Pages: 1241–1246, M. Dostal, C. Weber-Schoendorfer, J. Sobesky and C. Schaefer

    Article first published online : 22 OCT 2012, DOI: 10.1111/ene.12001